Purchase Order 75N92B20P00052

This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Otogenetics Corporation, a minority-owned, small disadvantaged business, for laboratory supplies and other functions. The contract has a ceiling value of $80,000.00 and a period of performance that ends on April 1, 2016. Otogenetics Corporation is a next-generation sequencing laboratory service provider that specializes in services such as whole exome...

Otogenetics Corporation, a minority-owned, small disadvantaged business, has been awarded a $24,849 firm-fixed-price purchase order contract by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases. The contract, which is not set aside for any specific business category, is for the provision of next-generation sequencing laboratory services, including whole exome sequencing, clinical genetic testing, and data analysis, to support research...

This federal contract award with ID 75N90019P00629 was issued by the National Institutes of Health (NIH) Clinical Center to Cell Line Genetics, Inc. for $11,200.00. The contract is for a firm fixed-price purchase order with a performance period ending on June 30, 2020. The contract was not set aside for any special type of business. Cell Line Genetics, Inc. is a for-profit organization that is minority-owned, woman-owned, and Hispanic American-owned. This award appears to be related to a...

This is a sole-source firm-fixed-price contract awarded by the National Institutes of Health (NIH) Clinical Center to Prevention Genetics LLC, a for-profit limited liability company, to provide specialized genetic testing services. The contract, valued at $60,000.00, is for the continuation of genetic analysis of the TNXB and CAH-X genes to support the NIH's ongoing Natural History Study of Patients with Excess Androgens, protocol #06-CH-0011. Prevention Genetics is the only CLIA-certified...

This firm fixed-price purchase order was awarded by the Office of the Chief Operating Officer (a civilian agency), a component of the National Institutes of Health (NIH), to Genedx, LLC, a for-profit limited liability company. The $81,666 contract is for medical laboratory testing services, specifically genetic testing and diagnostic services. Genedx, a wholly owned subsidiary of Opko Health, Inc., provides comprehensive genetic testing, including mutation analysis, exome and genome...

Microgenics Corporation, a clinical diagnostics division of Thermo Electron Corporation, has been awarded a firm fixed price delivery order valued at $22,560.20 from the Defense Health Agency. The order is being issued under an indefinite-delivery contract vehicle to provide opiates reagent kits in support of substance abuse testing and treatment programs across military medical facilities. Performance will take place in Fremont, California through August 2023. As a long-time supplier of...

This federal contract award was issued by the National Institutes of Health (NIH) Clinical Center to PreventiOnGenetics LLC, a for-profit limited liability company specializing in genetic testing services. The $9,700 Firm Fixed Price Purchase Order contract has an ultimate completion date of April 30, 2019. PreventiOnGenetics is an experienced provider of genetic analysis services to federal agencies, holding several Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs and...

Genedx, LLC, a division of Opko Health, Inc., has been awarded a $25,000 firm fixed price purchase order by the National Institutes of Health's National Human Genome Research Institute to provide exome and genome sequencing with optional mitochondrial testing for various patients. The contract has a period of performance of just over one year, running from September 2023 through August 2024. Genedx will perform the sequencing and testing services at its laboratory location in Montgomery Village,...

This is a firm fixed-price purchase order contract awarded by the Office of the Chief Operating Officer at the National Institutes of Health (NIH) to Genedx, LLC, a for-profit limited liability company, for medical laboratory testing services. The contract award, valued at $97,833.65, has a performance period from January 14, 2016, to an ultimate completion date of the same day. Genedx, a wholly owned subsidiary of Opko Health, Inc., is a leading provider of genetic testing and diagnostic...

This firm fixed-price purchase order was awarded to Novogene Corporation Inc., a minority-owned small business, by the National Institute of Child Health and Human Development for gene expression profiles (Alirocumab neuroinflammation apoptosis) in the amount of $54,080.00. The award is not associated with a set-aside and is based on a competitive solicitation for providing and analyzing gene expression and complete DNA library preparation, NovaSeq PSK9 (sequencing), and customized analysis....